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아마도 당 생물학 연구실의 일원으로서는 마지막 실험이 될 Cell counting
을 마치고 컴퓨터 앞에 앉아 글을 씁니다. 오늘로 2015년도 이틀이 남았습니
다, 한 해의 끝에 서서 지난 4년을 되돌아보니 설레면서도 동시에 마음이 복
잡합니다. 조금은 막연하고, 조금은 큰 꿈을 가지고 실험실에 처음 발을 딛게
된 지 4년, 그 꿈의 한 부분을 예쁘게 포장해서 세상에 내놓을 수 있게 되기
까지 지도하고 도와주신 교수님과 곁에서 응원과 격려를 주셨던 분들께 서투
르지만 감사의 말씀을 드리고 싶습니다.
먼저 저에게 O-GlcNAc의 세계를 알려주시고 연구자로서의 지금의 저를
있게 해주신 조진원 교수님께 진심으로 감사의 마음을 전하고 싶습니다. 3년간
연구를 수행하면서 교수님의 끝없는 배려와 실험에서 막힐 때마다 해주신 조
언, 지도 덕분에 무사히 연구를, 그리고 학업을 마칠 수 있었습니다. 끝까지
믿어주신 덕분에 좋은 결과로 학업을 마무리할 수 있어 감사드립니다. 또한, 
바쁘신 와중에 논문 심사에 응해 주시고, 실험에 대해 아낌없이 조언해 주시
고 논문이 아름다운 형태로 빛을 볼 수 있게끔 도와주신 이태호 교수님, 김지
현 교수님께 감사를 드립니다.
4년간 가장 가까운 곳에서 지낸 당 생물학 연구실 식구들에게도 감사의
인사를 하고 싶습니다. 처음 실험실 생활을 시작할 때 공부도 실험도 많이 도
와주시고 가이드 해주신 한별오빠, 선택한 진로를 격려해주시고 졸업하는 데
있어 끝없는 지원을 주신 현규오빠, 조교님으로 만나 의지 되는 실험실 언니
가 되어주신 인숙언니, 마지막까지 도와주셔서 감사한 연정언니, 입학하면 잘
챙겨주겠다고 한 약속을 지켜주신 은아언니, 자주 뵙지는 못했지만 중국에서
맥주를 나눠주신 양신언니, 그리고 졸업을 목전에 두고 한창 바쁠 동기 진원
오빠, 의욕 만만하고 열심히 하는 게 보여 걱정이 안 되는 든든한 정화까지, 
지면이 부족 할 정도로 많이 받은 배려와 도움 그리고 상냥함에 감사를 전하
고 앞으로의 일에서 행복과 축복이 따르길 바랍니다. 또한, 함께 실험실 생활
을 한 학부생 친구들, 그리고 그중에서도 PCR 트러블을 한 방에 날려준 미다
스의 손 우택이에게 감사를 표합니다.
지금은 졸업하셨지만, 언제나 차근차근히 실험을 가르쳐 주신 호중 오빠, 
이전 프로젝트로 고생할 때 많은 조언을 주셨던 수진 언니, 그리고 마지막으
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Abstract
O-GlcNAcylation is a post-translational modification on nuclear and cytoplasmic 
proteins, attached to and removed from serine or threonine residues by O-GlcNAc 
transferase (OGT) and O-GlcNAcase (OGA). O-GlcNAcylation is known to affect 
various cellular mechanisms, one of which is cell proliferation. The mitogen-activated 
protein kinase/extracellular signal-regulated kinase (MAPK/ERK) pathway is involved in 
cell proliferation, and activation of this pathway if known to increase OGT expression 
and O-GlcNAcylation. 
This study aims to identify presence of O-GlcNAcylation in the MAPK pathway, 
specifically on ERK2, and determine the function of ERK2 O-GlcNAcylation in the 
pathway. Here we discovered that OGA inhibition increased nuclear localization of ERK2, 
indicating a relevance between the MAPK pathway and O-GlcNAcylation. Through 
immunoprecipitation and lectin precipitation of ERK2, we identified O-GlcNAcylation 
on both endogenous and exogenous ERK2. Co-immunoprecipitation results of MEK1 and 
ERK2 showed that OGT induced O-GlcNAcylation change corresponded to an increase 
in ERK2-MEK1 interaction. Examination of subcellular fractionation results showed that 
upon OGT overexpression, ERK2 nuclear localization was decreased.
In conclusion, we have observed that ERK2 is O-GlcNAcylated, and that this 
modification increased the interaction between ERK2 and MEK1, leading to decreased 
nuclear localization of ERK2 in HEK293 cells.
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Chapter 1. Introduction
A crucial modulator in a multitude of cellular mechanisms, O-linked β-N-
acetylglucosamine (O-GlcNAc) modification – also known as O-GlcNAcylation – is a 
post-translational single sugar modification occurring on serine and threonine residues of 
nuclear and cytoplasmic proteins1. 
O-GlcNAc is dynamically attached to and removed from proteins in response to cellular 
cues, through the functions of O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA)1. 
2-3% of glucose entering the cell is processed by the hexosamine biosynthetic pathway 
(HBP) to produce uridine 5’-diphospho-N-acetylglucosamine (UDP-GlcNAc). This UDP-
GlcNAc is used as substrate by OGT to modify proteins, resulting in O-GlcNAcylation 
on proteins2,3,5. Since O-GlcNAc modification can occur on serine and threonine residues, 
it can reciprocally interplay with phosphorylation. The O-GlcNAcylation may occur on 
the same site as a phosphorylation or an adjacent site to a phosphorylation1,4. Through 
this reciprocal relationship the two modifications can either positively or negatively affect 
one another’s modification and function4.
Since UDP-GlcNAc, a substrate for O-GlcNAcylation is composed of many molecules 
related to energy, O-GlcNAc is thought to function as a nutrient sensor3,5,6. It is also 
implicated in a variety of cellular mechanisms, one of which is cell proliferation7. In 
idiopathic pulmonary arterial hypertension (IPAH) disease cells which exhibit increased 
cell proliferation, the activity of HBP was also found to be augmented. Down regulation 
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of OGT through siRNA knockdown in these cells resulted in decreased smooth muscle 
cell proliferation8. In a different research it was reported that cells lacking the HBP rate-
limiting enzyme glutamine:fructose-6-phosphate amidotransferase (GFAT) showed not 
only decreased O-GlcNAc but also decreased cell proliferation9. Thus we sought to 
understand the impact of O-GlcNAcylation on the pathways regulating cell proliferation.
In order to study the relevance of O-GlcNAcylation to cell proliferation, the 
MAPK/ERK signaling pathway was chosen. The MAPK-ERK pathway is a cellular 
signaling pathway consisting of a kinase cascade that transmits signals initiated by 
extracellular stimuli (ex. growth factor, cytokines) to their intracellular targets. The 
pathway is most prominently known to be involved in cell proliferation7.
  Three kinases Raf, MEK1/2 and ERK1/2 relay signals received from membrane 
receptors (ex. receptor-linked tyrosine kinases) by phosphorylating their downstream 
kinases. The kinase cascade ends with the phosphorylation of ERK1/2 which is then 
activated10. The activated ERK1/2 goes on to phosphorylate its cytosolic targets, or 
localizes to the nucleus to phosphorylate its nuclear targets such as transcription factors 
(ex. c-Fos), enabling production of proteins which prepare the cell for proliferation10,11. 
  The kinases ERK1 and 2 possess 84% sequence identity, with the two isoforms 
distributed differently across tissues12. However, it has been studied that while ERK1 
knock out in mice was not detrimental to growth, ERK2 knock out led to an early 
embryonic death13,14,15. These researches have supported the claim that ERK2 was 
capable of substituting for ERK1. Therefore we chose ERK2 as our matter of study. 
- 14 -
  Human ERK2 is activated upon phosphorylation at theronine 185 and tyrosine 187 by 
MEK. Following activation, threonine 190 is phosphorylated by autocatalysis16,17. The 
phosphorylated ERK2 can then be localized to the nucleus to carry on phosphorylation of 
its substrates18. 
The relationship between the MAPK pathway and O-GlcNAc has not yet been studied 
in depth. One recent research showed that activation of the MAPK pathway through 
drugs led to an increase in OGT expression and consequently to an increase in O-
GlcNAcylation19. We were curious as to whether a reverse relationship existed, where an 
increase in O-GlcNAcylation would exercise an effect on the MAPK pathway.
In this study we found that ERK2, the last kinase of the MAPK pathway, is O-
GlcNAcylated. Under the conditions of increased ERK2 O-GlcNAcylation, interaction 
between ERK2 and MEK1 was found to be increased. From our experimental results we 
hypothesize that this interaction, enhanced by increased O-GlcNAc, leads to a decrease in 
nuclear localized ERK2
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Chapter 2. Materials and Methods
2.1 Cell culture
HEK293 cells were cultured in 25mM Dulbecco’s modified Eagle’s medium (Hyclone, 
Logan, UT) supplemented with 10% foetal bovine serum at 37°C in 5% CO2. Cells were 
cultured every 48 hours, seeded at 1:5 dilutions. 
2.2 Cell counting
HEK293 cells were seeded in 6-well plates, 10x104 cells per well. After treatment the 
cells were incubated with 0.25% Trypsin-EDTA (Gibco) for 5 minutes and then harvested. 
The cells were re-suspended in 25mM Dulbecco’s modified Eagle’s medium. 1:1 ratio 
diluted cell solution was prepared by mixing with 0.4% Trypan blue stain (Gibco) and 
incubating for 5 minutes. The stained cells were then transferred to Neubauer improved 
chamber (Marienfeld) and viable cells were counted under OLYMPUS CK2-TRC 
microscope. The number of cells in 0.1ul of cell solution was obtained by counting four 
large squares, then dividing the sum of the four cells by 4, and multiplying by dilution 
factor 2. The number of cell per ml was obtained by multiplying the cell number from 
previous calculation with 104. 
2.3 DNA plasmids and transfection
DNA plasmids used in the experiments are the following. FLAG-ERK2 and FLAG-
- 16 -
OGT were cloned into p3xFLAG-CMV™-7.1 Expression Vector (Sigma-Aldrich, St 
Louis, MO). Untagged pCMV-OGT was used in overexpression. MEK1 was cloned into 
pRK5 in frame with an N-terminal Myc epitope. For transfection polyethylenimine 
(Sigma-Aldrich, St Louis, MO) was used, at ratio of 3μl 1x polyethylenimine for 
transfection of 10μg DNA plasmid.
2.4 Cell lysis, cell fractionation
Cells were lysed using NET buffer (150 mM NaCl, 1% Nonidet P-40 [NP-40], 50 mM 
Tris-HCl and 1 mM EDTA, pH 8.0), supplemented with Protease Inhibitor Cocktail 
(Roche, Mannheim, Germany), 1mM DTT, 5mM NaF and 1mM Na3VO4, and incubated 
on ice for 30 minutes with vortexing every 5 minutes. 
Subcellular fractionation was carried out using hypotonic Buffer A (10 mM HEPES, 10 
mM KCl, 0.1 mM EDTA, 0.1 mM EGTA and 1 mM DTT) and extraction Buffer C(20 
mM HEPES, 400 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM DTT and 10% glycerol). 
Both buffers were supplemented with Protease Inhibitor Cocktail (Roche, Mannheim, 
Germany), 1mM DTT, 5mM NaF and 1mM Na3VO4. HEK293 cells were rinsed with 
PBS, then suspended in Buffer A. After 15 minute incubation in ice, the cells were 
vortexed with 0.5% NP-40. The extracts were centrifuged at 4000rpm, 4 min., 4°C. The 
cytoplasm fraction supernatant was placed in a new tube. The pellets were suspended in 
Buffer C and incubated on ice for 30 minutes with vortex every 5 minutes, then 
centrifuged at 15000rpm, 10 min., 4°C to obtain supernatant containing the nuclear 
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fraction.
Protein concentrations of the lysates were calculated by Bio-Rad protein assay 
(Hercules, CA). The lysates were mixed with 4xSDS sample buffer, and subjected to 
western blot.
2.5 Succinylated wheat germ agglutinin (sWGA) precipitation 
  For sWGA precipitation, 2~4mg of NET buffer cell lysates were incubated with PBS-
washed agarose-sWGA (Vector Lab) for 6 hours at 4°C. The sWGA beads were washed 3 
times with NET buffer (supplemented with protease inhibitor cocktail).  Precipitates 
were eluted by addition of 2x SDS sample buffer and boiling.
2.6 Immunoprecipitation
  For FLAG immunoprecipitation, 2~4 mg of NET buffer cell lysates were incubated 
with PBS-washed anti-FLAG M2 affinity Gel (sigma Aldrich) for overnight at 4°C. The 
anti-FLAG M2 affinity Gel was washed 3 times with NET buffer (supplemented with 
protease inhibitor cocktail).  Precipitates were eluted by addition of 2x SDS sample 
buffer and boiling.
2.7 SDS-PAGE, Western blotting
The protein samples obtained from cell lysis, subcellular fractionation, sWGA lectin 
precipitation and immunoprecipitation were subjected to SDS-PAGE and transferred to 
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nitrocellulose membranes (Amersham, Piscataway, NJ). The samples were loaded onto 
10–12% Bis-Tris NuPAGE gel (NOVEX, San Diego, CA) and separated according to size 
by electrophoresis and transferred to nitrocellulose membranes (GE Healthcare). The 
membranes were incubated in 5% skim milk TBS-T for 1 hour in room temperature and 
washed 3 times for 5 minutes by TBS-T. The membranes were then incubated with 
respective primary antibodies diluted to specific concentration in 1% skim milk TBS-T 
either overnight at 4°C or for 8 hours at room temperature. Again the membranes were 
washed 3 times for 5 minutes by TBS-T to remove excess antibodies. Finally the 
membranes were incubated with HRP-conjugated secondary antibodies diluted to 1:5000 
in TBS-T for 1 hour in room temperature, and washed 3 times for 5 minutes by TBS-T. 
Immunofluoresence was detected using an ECL system (GE Healthcare, Bio-Science).
2.8 Reagents and antibodies
ThiaMet-G, provided by Dr Kwan Soo Kim (Yonsei University, Seoul, Korea) was used 
at 50μM concentration, with incubation time of 24 hours. Antibodies were used against 
ERK2 (D-2, mouse monoclonal, Santa Cruz, Dallas, Texas), FLAG (F-3156, mouse 
monoclonal, Sigma-Aldrich, St Louis, MO), cMyc (B-14, mouse monoclonal, Santa Cruz, 
Dallas, Texas), α-tubulin (TU-02, mouse monoclonal, Santa Cruz), lamin A/C (#2032, 
rabbit polyclonal, Cell Signaling, Beverly, MA) and O-GlcNAc  detecting antibody 
CTD110.6  was purchased from Covance (Princeton, NJ). Prosi Prestained Protein 
Marker (P8500, GenDepot) was used to determine approximate size of western blots.
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Chapter 3. Results
3.1 Inhibition of OGA affects MAPK pathway by changing cellular localization of 
Extracellular signal-regulated kinase 2 (ERK2)
To observe how change in global O-GlcNAcylation impacted the MAPK/ERK pathway, 
HEK293 cells were incubated with OGA inhibitor ThiaMet-G for 18hours at 50μM 
concentration and lysed to obtain nucleus, cytoplasm and total lysate fractions. The 
samples were then separated by SDS-PAGE and Western blot was carried out. The 
amount of ERK2 in each subcellular fraction was evaluated by immunoblotting with 
ERK2 antibody (Fig.1A). Under increased O-GlcNAcylation conditions the ratio of the 
ERK2 localized to the nucleus was found to increase by 2.89 times compared to the ratio 
of ERK2 localized to the nucleus in control cells (Fig.1B).
  ThiaMet-G treatment also influenced proliferation of HEK293 cells. 24 hours 
following treatment with ThiaMet-G, the cells were harvested using trypsin and stained 
with 0.4% Trypan blue. The number of cells were counted using Neubauer improved 
counting chamber. We found that ThiaMet-G treated HEK293 cells showed greater cell 
proliferation compared to non-treated cells (Fig.1C). 
Through these experiments we showed that OGA inhibition by ThiaMet-G increased 
nuclear localization of ERK2, as well as enhanced cell proliferation of HEK293. Since 
localization of ERK2 to the nucleus is a sign of MAPK pathway activity18, thus we 
concluded that increased O-GlcNAc by inhibition of OGA affected the MAPK pathway.
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Figure 1. Inhibition of OGA affects MAPK pathway by changing cellular 
localization of Extracellular signal-regulated kinase 2 (ERK2). (A) HEK293 cells 
were treated with 50μM ThiaMet-G and incubated for 24 hours. The cells were harvested 
and subjected to fractionation to obtain nucleus, cytoplasm and total lysate fractions. 
Western blotting of fractions was done by ERK2, O-GlcNAc, lamin A/C, and α-tubulin. 
(B) The ratio of nuclear/cytoplasmic ERK2 was obtained by quantification and 
normalization. Nuclear ERK2 was normalized to the amount of lamin A/C, and 
cytoplasmic ERK2 was normalized to the amount of α-tubulin. The values are an average 
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obtained from two separate experiments. (C) HEK 293 cells were treated with 25μM or 
50μM ThiaMet-G for 24hours. The cells were then treated with trypsin and counted using 
0.4% Trypan blue staining and Neubauer improved counting chamber. The value 
indicates number of cell per ml.
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3.2 ERK2 is O-GlcNAcylated under high glucose conditions in HEK293 cells
In the previous experiment, under increased O-GlcNAcylation condition, the 
intracellular distribution of ERK2 was found to be increased in the nucleus. To determine 
whether ERK2 is O-GlcNAcylated, lectin precipitation and immunoprecipitation were
carried out on endogenous and exogenous ERK2.
  HEK293 cells were transfected with pCMV-OGT or treated with ThiaMet-G. The cells 
were lysed and the lysate was used in lectin precipitation using O-GlcNAc moiety 
binding sWGA beads. As a result, endogenous ERK2 was precipitated, and the amount of 
precipitated ERK2 increased under OGT overexpression and ThiaMet-G treatment 
conditions (Fig.2A). To confirm sWGA binding of ERK2, Flag-ERK2 and pCMV-OGT 
were co-expressed in HEK293 cells and precipitated with sWGA. Flag-ERK2 was 
precipitated with sWGA, and the amount of precipitated Flag-ERK2 increased under 
OGT overexpression condition (Fig 2B). 
To confirm presence of O-GlcNAcylation on ERK2 using a more direct approach, 
immunoprecipitation by anti-FLAG M2 affinity Gel was carried out on cells transfected 
with Flag-tagged ERK2 and pCMV-OGT. Immunoprecipitated Flag-ERK2 was 
immunoblotted using O-GlcNAc antibody CTD 110.6. O-GlcNAcylation was detected on 
Flag-ERK2 and found to be increased under OGT overexpression. (Fig. 2C)
Through these experiments O-GlcNAcylation on both endogenous and exogenous 
ERK2 was observed, and found to be increased under O-GlcNAc enhanced conditions.
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Figure 2. ERK2 is O-GlcNAcylated under high glucose conditions in HEK293 cells. 
(A) HEK293 cells were transfected with pCMV-OGT or treated with 50μM ThiaMet-G. 
Endogenous ERK2 was precipitated from lysates using sWGA. Western blotting was 
done by ERK2, O-GlcNAc and α-tubulin. (B) Flag-ERK2 was transfected into HEK293 
cells together with pCMV-OGT. Each cell lysate was immunoprecipitated with anti-
FLAG M2 affinity Gel. O-GlcNAc was detected by CTD110.6 antibody. Western blotting 
was done by Flag, O-GlcNAc, OGT and α-tubulin. (C) Flag-ERK2 was transfected into 
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HEK293 cells together with pCMV-OGT. Flag-ERK2 was precipitated from lysates using 
sWGA. ERK2 was detected by Flag antibody. Western blotting was done by Flag, OGT, 
O-GlcNAc and α-tubulin.
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3.3 Increased O-GlcNAcylation on ERK2 increases interaction between ERK2 and 
MAPK/ERK Kinase 1 (MEK1)
After determining O-GlcNAcylation of ERK2 (Fig.2.), we aimed to determine the 
function of the modification. ERK2 is known to interact with its upstream kinase MEK1 
through its cytosolic retention sequence/common docking domain (CRS/CD), and MEK1 
with ERK through its D domain (Lysine3, Lysine 4, Lysine 5)20,21. Besides acting as 
upstream kinase to ERK2, MEK1 has been identified as a cytosolic retention molecule to 
ERK220. Increase in the amount of MEK1 is known to sequester ERK2 to the cytosol20.
To observe the effect of increased O-GlcNAc on the interaction between ERK2 and 
MEK1, HEK293 cells were overexpressed with Flag-ERK2, Myc-MEK1 and pCMV-
OGT. The transfected cells were then immunoprecipitated using FLAG bead and 
subjected to Western blotting. The amount of MEK1 interacting with ERK2 was detected 
using Myc antibody. We found that Immunoprecipitated ERK2 was indeed interacting 
with MEK1, and that the amount of MEK1 interacting with ERK2 increased upon OGT 
overexpression (Fig.3).
As a result we determined that increased O-GlcNAcylation by OGT expression, which 
increased O-GlcNAcylation on ERK2, enhanced the interaction between ERK2 and 
MEK1.
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Figure 3. Increased O-GlcNAcylation on ERK2 increases interaction between ERK2 
and MAPK/ERK Kinase 1 (MEK1). Myc-MEK1 and Flag-ERK2 were overexpressed 
together with pCMV-OGT in HEK293 cells. Each cell lysate was immunoprecipitated 
with anti-FLAG M2 affinity Gel. Flag antibody was used to detect ERK2, and cMyc 
antibody was used to detect MEK1. OGT, O-GlcNAc and α-tubulin were immunoblotted 
using respective antibodies.
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3.4 Nuclear localization of ERK2 is decreased under increased O-GlcNAc 
modification conditions
MEK1 plays a role in both promoting and impeding nuclear translocation of ERK2, by 
means of phosphorylation and molecular interaction10,20,21. Because an increase in O-
GlcNAcylation by OGT overexpression was found to enhance molecular interaction 
between ERK2 and MEK1 (Fig.3.), we examined whether this change resulted in a 
change in the cellular distribution of ERK2.
HEK293 cells were each transfected with FLAG-OGT or MEK1. The cells were put 
through subcellular fractionation to obtain nucleus, cytoplasm, and total lysate fractions. 
The samples were then Western blotted for endogenous ERK2 using ERK2 antibodies. 
We observed that the positive control MEK1 overexpression did decrease nuclear 
localization of ERK2. Nuclear localization of ERK2 was also decreased under OGT 
overexpression conditions (Fig.4A,B).
From these results we could extrapolate that OGT overexpression condition, which 
increased the interaction between ERK2 and MEK1, lead to cytosolic retention of ERK2 
without increase in total amount of MEK1.
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Figure 4. Nuclear localization of ERK2 is decreased under increased O-GlcNAc 
modification conditions. (A) HEK293 cells were transfected with vehicle (Mock), 
FLAG-OGT and Myc-MEK1 each. Cells were subjected to subcellular fractionation to 
obtain nucleus, cytoplasm and total lysate cell fractions. Western blotting of subcellular 
fractions was done by ERK2, lamin A/C, α-tubulin, Flag, cMyc and O-GlcNAc 
antibodies. (B) The ratio of nuclear/cytoplasmic ERK2 was obtained by quantification 
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and normalization. Nuclear ERK2 was normalized to the amount of lamin A/C, and 
cytoplasmic ERK2 was normalized to the amount of α-tubulin. The values are an average
obtained from two separate experiments.
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Chapter 4. Discussion
The prospect of a reciprocal relationship existing between O-GlcNAc and the MAPK 
kinase pathway was highly probable, considering the function of O-GlcNAcylation as 
glucose sensitive nutrient sensor3,5,6. However, the effect of changed O-GlcNAc on the 
MAPK pathways has not yet been studied in detail, thus this research aimed to ascertain 
whether an association existed between the two.
In this study, we demonstrated that the MAPK pathway is influenced by OGA inhibitor 
ThiaMet-G-induced change in O-GlcNAcylation, in the form of increased nuclear 
localization of ERK2. Since ERK2’s cellular distribution was affected by ThiaMet-G, we 
examined whether ERK2 was O-GlcNAcylated. ERK2 O-GlcNAcylation was detected 
and this modification was successfully linked to a change in ERK2 function. Under 
ERK2 O-GlcNAcylation conditions the interaction between ERK2 and MEK1 was found 
to be enhanced. Furthermore, since MEK1 could function as cytosolic retention molecule 
to ERK220, we hypothesized that O-GlcNAc enhanced ERK2-MEK1 interaction may 
retain ERK2 in the cytosol. The Western blot of cellular fractionation confirmed our 
hypothesis, with more ERK2 retained in the cytosolic fractions under OGT 
overexpression conditions.
  Combining the results of this research we came to a tentative conclusion that the 
MAPK pathway was influenced by change in O-GlcNAcylation, and that the pathway’s 
final effector kinase, ERK2 was modified with O-GlcNAc. The O-GlcNAcylation on 
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ERK2 enhanced ERK2-MEK1 interaction, possibly leading to decreased nuclear 
localization of ERK2.
During the research we faced several complications. The first was the conflicting 
subcellular fractionation result of OGA inhibitor ThiaMet-G and OGT overexpression 
conditions. While both ThiaMet-G and OGT overexpression resulted in increased global 
O-GlcNAc, the effects of the two conditions on the nuclear-cytosolic localization of 
ERK2 were markedly different. ERK2 was dominantly localized to the nucleus under 
ThiaMet-G treatment (Fig.1A), whereas it was dominantly retained in the cytosol under 
OGT overexpression conditions (Fig.3A). We hypothesized that although both ThiaMet-G 
treatment and OGT overexpression resulted in increased global O-GlcNAcylation, 
because the two conditions employ different mechanisms to achieve the result, ERK2 
localization was affected differently. ThiaMet-G enhances global O-GlcNAcylation by 
inhibiting OGA from removing existing O-GlcNAcylation, whereas OGT overexpression 
increases total OGT proteins allowing O-GlcNAcylation of yet unmodified proteins. Our 
hypothesis is that the O-GlcNAcylation on ERK2 which enhanced interaction with 
MEK1 and subsequently influenced cytosolic retention is newly gained from OGT 
overexpression, but not from ThiaMet-G treatment. In order to confirm this hypothesis, 
identification of ERK2 O-GlcNAcylation by Mass spectrometry is required. By 
comparing ERK2 under ThiaMet-G treatment and OGT overexpression conditions, it may 
be possible to determine whether ERK is differently modified under the two 
circumstances, which would shed light on the differing subcellular fractionation result of 
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this research.
The second limitation of this study was the effectiveness of coimmunoprecipitation as 
a method for studying interaction between two proteins, in our case ERK2 and MEK1. 
While we were successful in detecting MEK1 on immunoprecipitated ERK2, we could 
not achieve the reverse. Immunoprecipitation of MEK1 using A/G beads and Myc 
antibody was successful, but due to an excess of background we could not detect the 
presence of ERK2. 
Third, while interaction between ERK2 and MEK1 increased under OGT 
overexpression (Fig.3), we cannot conclude that the O-GlcNAcylation on ERK2 alone 
functioned in enhancing ERK2-MEK1 interaction. To be certain that the increase in 
ERK2 O-GlcNAcylation was crucial to enhanced ERK2-MEK1 interaction, an in vitro
binding assay (ex. GST pull-down) is required to eliminate all other cellular variables.
Though limitations existed, the research fulfilled its aim of establishing a connection 
between O-GlcNAcylation and the MAPK pathway, through its study focused on ERK2. 
Our findings suggest that an influencing relationship exists between O-GlcNAcylation 
and the MAPK pathway, which through the regulation of ERK2 cellular localization, may 
possibly be further implicated in influencing cell proliferation.
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Chapter 5. Summary
1. When global O-GlcNAcylation is increased by OGA inhibition, ERK2 is dominantly 
localized in the nucleus.
2. ERK2 is O-GlcNAcylated in HEK293, and O-GlcNAcylation increases under OGT 
overexpression.
3. When O-GlcNAcylation on ERK2 is increased, interaction between ERK2 and 
MEK1 is enhanced.
4. When global O-GlcNAcylation is increased by OGT overexpression, ERK2 is 
decreased in the nucleus.
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국문 요약
Extracellular Signal-Regulated Kinase 2의 O-GlcNAc 수식화
기능 연구
연세대학교 대학원
융합오믹스 의생명과학과
윤지영
O-GlcNAcylation은 세포질과 핵에 존재하는 단백질들에 일어나는 post-
translational 수식화의 한 종류이다. 이 수식화는 O-GlcNAc transferase (OGT)와
O-GlcNAcase (OGA) 단백질들의 작용을 통해 serine 또는 threonine 아미노산에
붙여지고 또한 제거된다. O-GlcNAcylation은 다양한 세포 내 대사와 신호전달
에 관여하고 있고, 이 중 하나가 세포 증식이다. Mitogen-activated protein 
kinase/extracellular signal-regulated kinase (MAPK/ERK) 신호전달체계는 세포 증식
에 있어 중요한 역할을 하고, 이 신호전달 체계의 활성화는 OGT 발현 증가
및 O-GlcNAcylation 증가로 이어지는 것으로 밝혀져 있다.
본 연구는 MAPK 신호전달 체계에 속한 ERK2 단백질의 O-GlcNAcylation 여
부를 규명하려 하였고, 또한 ERK2 단백질의 O-GlcNAcylation이 MAPK 신호전
달 체계에서 어떠한 역할을 하는지 알아보자고 하였다. 우리는 OGA 저해제로
인해 ERK2가 핵에 집중되는 것을 확인하여 O-GlcNAcylation과 MAPK 신호전
달 체계 사이에 연관성을 찾았다. Immunoprecipitation과 lectin precipitation을 통
해 exogenous, 그리고 endogenous한 ERK2에 O-GlcNAcylation이 존재하는 것을
확인하였다. ERK2와 MEK1을 co-immunoprecipitation한 결과, OGT 과발현으로
인한 ERK2 O-GlcNAcylation 증가와 함께 ERK2-MEK1 사이의 상호작용이 증가
함을 볼 수 있었다. 핵-세포질 분리 실험을 통해 OGT 과발현 조건에서 ERK2
는 핵에서 줄어 드는 것을 확인하였다.
이 실험을 통해 우리는 ERK2가 O-GlcNAcylation 되어 있고, 또한 이 수식
화증가로 인해 ERK2-MEK1 사이의 상호 작용이 증가하게 되어 궁극적으로는
HEK293 세포의 핵에서 ERK2가 줄어드는 것을 발견하였다.
- 38 -
Keywords: O-GlcNAc, OGT, ThiaMet-G, MAPK pathway, cell proliferation, ERK2, 
nuclear localization
